Kumquat Biosciences Inc.
Clinical trials sponsored by Kumquat Biosciences Inc., explained in plain language.
-
New cancer drug enters human testing: could it shrink tough tumors?
Disease control Recruiting nowThis is the first study in people testing KQB168, a new cancer drug, for adults with advanced solid tumors that have stopped responding to standard treatments. Researchers want to find the safest dose of KQB168 when taken alone or combined with another cancer drug (pembrolizumab)…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New cancer drug enters first human trials for advanced solid tumors
Disease control Recruiting nowThis early-stage study is testing a new cancer drug called KQB198 in adults with advanced solid tumors that have spread or cannot be surgically removed. Researchers want to find the safest dose of KQB198 when taken alone or combined with other cancer drugs, and see if it helps sh…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New pill targets 'Undruggable' cancer mutation in first human test
Disease control Recruiting nowThis is the first study in people to test KQB548, an oral pill designed to target a specific genetic change (KRAS G12D) found in some advanced solid tumors like pancreatic, colorectal, and lung cancers. The main goals are to find a safe dose, see how the body processes the drug, …
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC